DESIREE CASTONGUAY: Open Payments
NPI 1730578535 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$574 in 23 payments from 6 companies in 2025. Trend: 2023 $446 · 2024 $730 · 2025 $574
Food & beverage: $521Education: $53
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $262 |
| Regeneron Healthcare Solutions, Inc. | 5 | $154 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| SANOFI-AVENTIS U.S. LLC | 1 | $53 |
| Merck Sharp & Dohme LLC | 1 | $32 |
| Optinose US, Inc. | 1 | $15 |
Products named: DUPIXENT, NUCALA, KEYTRUDA, Xhance.
Industry payments across NV — which companies pay providers there.
